LILLY ELI & CO
Add to watch list Add to watch list

Company

profile

overview

growth

risk

operations

valuation

Statements

income

balance sheet

cash flows

Insiders

Buzz Board

  • Compare against:
  • Note: Not all companies will have their earnings statement processed. see following for details. About us

LILLY ELI & CO Earnings Overview

Company overview section gives a snap shot of company and stock performance to quickly determine if the company is worth looking into.

It contains the stock performance overview, and stock volatility expressed in terms of stock turnover ratio (i.e. the average amount of time investors are holding on to their stocks) to give insight into the general mood of investors.

Company perforance is expressed in terms of revenue, net income, cash flows, debt and equity and several risk parameters, to asses the risk/reward profile of the company.

Stock data
Ticker LLY
Industry Pharmaceutical Preparations
Market value $38,256,737,520
Price per share $34.66
52 week range $32.25 - $37.77
Dividend $5.77
Shares 1,103,772,000
P/E 8.84
EPS $3.92
Stock volatility ( Share turnover )
past week 169 days
past month 122 days
past year 149 days
Earnings ( values in Thousands )200920082007200620052004200320022001200019991998199719961995199419931992
Revenue$21,836,000$20,371,900$18,633,500$15,691,000$14,645,300$13,857,900$12,582,500$11,077,500$11,542,500$10,862,200$10,002,900$9,236,800$7,987,700$7,346,600$6,763,800$5,711,600$5,198,500$6,167,300
Cost of sales$4,247,000$4,376,700$4,248,800$3,546,500$3,474,200$3,223,900$2,675,100$2,176,500$2,160,200----$2,015,100$1,946,000$2,118,400$1,885,700$1,679,700$1,448,000$1,897,000
Gross profit$17,589,000$15,995,200$14,384,700$12,144,500$11,171,100$10,634,000$9,907,400$8,901,000$9,382,300$10,862,200$10,002,900$7,221,700$6,041,700$5,228,200$4,878,100$4,031,900$3,750,500$4,270,300
Sales, general and administrative$6,892,500$6,626,400$6,095,100$4,889,800$4,497,000$4,284,200$4,055,400$3,424,000$3,417,400$5,284,000$4,855,600$2,658,300$2,233,100$1,991,900$1,854,000$1,398,300$1,332,400$1,624,200
Research and development$4,326,500$3,840,900$4,232,300$3,129,300$3,025,500$3,083,300$2,350,200$2,233,300$2,425,600$2,018,500$1,783,600$1,738,900$1,370,200$1,189,500$1,042,300$897,100$755,000$924,900
Restructuring----$302,500$945,200$1,245,300$603,000$382,200----------------$66,000$1,032,600$565,700
Asset impairment----------------$121,400--$87,400--$97,800----------
Other expenses$1,012,200$6,835,500------------$29,400----$134,700------------
Operating income$5,357,800($1,307,600)$3,754,800$3,180,200$2,403,300$2,663,500$3,119,600$3,243,700$3,388,500$3,559,700$3,276,300$2,689,800$2,340,600$2,046,800$1,981,800$1,670,500$630,500$1,155,500
Other income----$122,000$237,800$314,200$330,000$203,100$293,700$280,700$481,300$152,900$149,300$793,200$273,300$70,100$131,900$32,300$26,800
Net interest expense (income)----------$51,600$61,000$79,700$146,500$182,300$183,800$181,300$232,700$288,800$286,300$103,800----
Income before taxes$5,357,800($1,307,600)$3,876,800$3,418,000$2,717,500$2,941,900$3,261,700$3,457,700$3,522,700$3,858,700$3,245,400$2,657,800$2,901,100$2,031,300$1,765,600$1,698,600$662,800$1,182,300
Taxes$1,029,000$764,300$923,800$755,300$715,900$1,131,800$700,900$749,800$742,700$800,900$698,700$568,700$885,200$507,800$459,000$513,500$198,000$354,700
Income before extraordinary items$4,328,800($2,071,900)$2,953,000$2,662,700$2,001,600$1,810,100$2,560,800$2,707,900$2,780,000$3,057,800$2,546,700$2,089,100$2,015,900$1,523,500$1,306,600$1,185,100$464,800$827,600
Discontinued operations--------------------$174,300$8,800($2,401,000)--$984,300$101,000$26,300--
Cumulative effect of accounting change--------$22,000----------------------$10,900$118,900
Net income$4,328,800($2,071,900)$2,953,000$2,662,700$1,979,600$1,810,100$2,560,800$2,707,900$2,780,000$3,057,800$2,721,000$2,097,900($385,100)$1,523,500$2,290,900$1,286,100$480,200$708,700